Adrien Contejean

11PUBLICATIONS
21CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Predictive and prognostic markersRespiratory diseasesPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 06, 2024
Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm.

Sabine Khalife-Hachem, Arnaud Pages, Elie Akoury

|Aug 30, 2023
Increased risk of infection reporting with anti-BCMA bispecific monoclonal antibodies in multiple myeloma: A worldwide pharmacovigilance study.

Adrien Contejean, Cécile Janssen, Frédérique Orsini-Piocelle

|Jul 04, 2023
Clinico-biological features, treatment and prognosis of primary myeloid sarcoma: A French retrospective multi-centric observational study.

Maya Belhadj, Barbara Burroni, Olivier Kosmider

|Jun 01, 2023
Advances in antibacterial treatment of adults with high-risk febrile neutropenia.

Adrien Contejean, Alexis Maillard, Etienne Canouï

|Mar 25, 2023
Assessing the risk of adverse pregnancy outcomes and birth defects reporting in women exposed to ganciclovir or valganciclovir during pregnancy: a pharmacovigilance study.

Adrien Contejean, Marianne Leruez-Ville, Jean-Marc Treluyer

|Mar 29, 2022
Antimicrobial stewardship in high-risk febrile neutropenia patients.

Adrien Contejean, Salam Abbara, Ryme Chentouh

Pageof 2

Frequent Collaborators

3 joint publications

Caroline Charlier

3 joint publications

Laurent Chouchana

1 joint publications

Pierre Frange

1 joint publications

Vassilis Tsatsaris